These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12139233)

  • 1. Paradigms for primary prevention of ovarian carcinoma.
    Barnes MN; Grizzle WE; Grubbs CJ; Partridge EE
    CA Cancer J Clin; 2002; 52(4):216-25. PubMed ID: 12139233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoprevention and prophylactic surgery in ovarian carcinoma].
    Deffieux X; Touboul C; Uzan C; Faivre E; Frydman R; Fernandez H; Morice P
    J Gynecol Obstet Biol Reprod (Paris); 2007 Dec; 36(8):756-63. PubMed ID: 17719183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy and ovarian cancer: a review.
    Barnes MN; Deshane JS; Rosenfeld M; Siegal GP; Curiel DT; Alvarez RD
    Obstet Gynecol; 1997 Jan; 89(1):145-55. PubMed ID: 8990458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of ovarian cancer.
    Hoekstra A; Rodriguez GC
    Cancer Treat Res; 2009; 149():3-34. PubMed ID: 19763429
    [No Abstract]   [Full Text] [Related]  

  • 5. Noncontraceptive health benefits of oral steroidal contraceptives.
    Mishell DR
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention.
    Fathalla MF
    Int J Gynaecol Obstet; 2016 Mar; 132(3):356-8. PubMed ID: 26876699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of retinoids in the chemoprevention of cancer.
    de Palo G; Formelli F
    Drug Saf; 1995 Oct; 13(4):245-56. PubMed ID: 8573297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of ovarian cancer.
    Hanna L; Adams M
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):339-62. PubMed ID: 16368271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in ovarian cancer: from the laboratory to the clinic.
    Sood AK; Buller RE
    Obstet Gynecol; 1998 Aug; 92(2):312-9. PubMed ID: 9699774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and NSAIDs: effects in breast and ovarian cancers.
    Crew KD; Neugut AI
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of ovarian cancer.
    Brewer MA; Mitchell MF; Bast RC
    In Vivo; 1999; 13(1):99-106. PubMed ID: 10218141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights regarding pharmacologic approaches for ovarian cancer prevention.
    Rodriguez G
    Hematol Oncol Clin North Am; 2003 Aug; 17(4):1007-20, x. PubMed ID: 12959189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for estimating ovarian cancer risk: application for preventive oophorectomy.
    Giannakeas V; Sopik V; Shestopaloff K; Iqbal J; Rosen B; Akbari M; Narod SA
    Gynecol Oncol; 2015 Nov; 139(2):242-7. PubMed ID: 26341709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.
    Karnezis AN; Cho KR
    Clin Obstet Gynecol; 2017 Dec; 60(4):789-800. PubMed ID: 28719396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
    Rodríguez-Burford C; Barnes MN; Oelschlager DK; Myers RB; Talley LI; Partridge EE; Grizzle WE
    Clin Cancer Res; 2002 Jan; 8(1):202-9. PubMed ID: 11801560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.